Cover Story: Preventing breast Ca with aromatase inhibitors
Publish date: December 1, 2003
Mohamed F. Mitwally, MD, PhD , Robert F. Casper, MD
Mohamed F. Mitwally, MD, PhD , Robert F. Casper, MD
With new research showing that aromatase inhibitors can dramatically cut the risk of recurring breast cancer, patients will probably have many questions about drugs like anastrozole and letrozole. Two experts review the scientific evidence on these valuable agents.